Generics - Sun Pharmaceutical Industries, Pharmaceutical

Filter

Popular Filters

Pfizer in $2.15 billion settlement from Teva and Sun for infringement of Protonix patent

12-06-2013

Global pharma behemoth Pfizer (NYSE: PFE) today (June 12) said it has reached a $2.15 billion settlement…

Gastro-intestinalsGenericsLegalNorth AmericaPatentsPfizerPharmaceuticalProtonixSun Pharmaceutical IndustriesTeva Pharmaceutical Industries

Takeda sells non-Colcrys URL Pharma generic business to Sun Pharma; Eisai divests Gliadel Wafer in USA

17-12-2012

Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), has entered into a definitive agreement…

Arbor PharmaceuticalsColcrysEisaiGenericsGliadelMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalSun Pharmaceutical IndustriesTakeda PharmaceuticalsURL Pharma

US Supreme Court ruling in Novo Nordisk Prandin case favors generic drugmakers

18-04-2012

The US Supreme Court yesterday reversed the US Court of Appeals for the Federal Circuit's April 2010…

Caraco PharmaceuticalDiabetesGenericsLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandiMetPrandinrepaglinideSun Pharmaceutical Industries

US FDA acts on cancer drugs shortages; move applauded by GPhA

22-02-2012

The US Food and Drug Administration this week spelt out a series of steps to increase the supply of critically…

APP PharmaceuticalsDoxilGenericsHospiraMarkets & MarketingmethotrexateNorth AmericaOncologyPharmaceuticalRegulationSun Pharmaceutical Industries

Sun Pharma offers to acquire remainder of Taro shares

20-10-2011

Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

Back to top